167 related articles for article (PubMed ID: 23936461)
1. Regulation of A1 by OX40 contributes to CD8(+) T cell survival and anti-tumor activity.
Lei F; Song J; Haque R; Haque M; Xiong X; Fang D; Croft M; Song J
PLoS One; 2013; 8(8):e70635. PubMed ID: 23936461
[TBL] [Abstract][Full Text] [Related]
2. Ligation of the OX40 co-stimulatory receptor reverses self-Ag and tumor-induced CD8 T-cell anergy in vivo.
Redmond WL; Gough MJ; Weinberg AD
Eur J Immunol; 2009 Aug; 39(8):2184-94. PubMed ID: 19672905
[TBL] [Abstract][Full Text] [Related]
3. Intracellular Galectin-3 Is Essential for OX40-Mediated Memory CD8
Amani MF; Rolig AS; Redmond WL
J Immunol; 2020 Oct; 205(7):1857-1866. PubMed ID: 32848035
[TBL] [Abstract][Full Text] [Related]
4. Activation of NF-kappaB1 by OX40 contributes to antigen-driven T cell expansion and survival.
Song J; So T; Croft M
J Immunol; 2008 Jun; 180(11):7240-8. PubMed ID: 18490723
[TBL] [Abstract][Full Text] [Related]
5. OX40 costimulatory signals potentiate the memory commitment of effector CD8+ T cells.
Mousavi SF; Soroosh P; Takahashi T; Yoshikai Y; Shen H; Lefrançois L; Borst J; Sugamura K; Ishii N
J Immunol; 2008 Nov; 181(9):5990-6001. PubMed ID: 18941188
[TBL] [Abstract][Full Text] [Related]
6. OX40 and Bcl-xL promote the persistence of CD8 T cells to recall tumor-associated antigen.
Song A; Tang X; Harms KM; Croft M
J Immunol; 2005 Sep; 175(6):3534-41. PubMed ID: 16148096
[TBL] [Abstract][Full Text] [Related]
7. In vivo antitumor function of tumor antigen-specific CTLs generated in the presence of OX40 co-stimulation in vitro.
Pham Minh N; Murata S; Kitamura N; Ueki T; Kojima M; Miyake T; Takebayashi K; Kodama H; Mekata E; Tani M
Int J Cancer; 2018 Jun; 142(11):2335-2343. PubMed ID: 29313971
[TBL] [Abstract][Full Text] [Related]
8. Anti-OX40 stimulation in vivo enhances CD8+ memory T cell survival and significantly increases recall responses.
Ruby CE; Redmond WL; Haley D; Weinberg AD
Eur J Immunol; 2007 Jan; 37(1):157-66. PubMed ID: 17183611
[TBL] [Abstract][Full Text] [Related]
9. The survival of memory CD4+ T cells within the gut lamina propria requires OX40 and CD30 signals.
Withers DR; Jaensson E; Gaspal F; McConnell FM; Eksteen B; Anderson G; Agace WW; Lane PJL
J Immunol; 2009 Oct; 183(8):5079-84. PubMed ID: 19786532
[TBL] [Abstract][Full Text] [Related]
10. During viral infection of the respiratory tract, CD27, 4-1BB, and OX40 collectively determine formation of CD8+ memory T cells and their capacity for secondary expansion.
Hendriks J; Xiao Y; Rossen JW; van der Sluijs KF; Sugamura K; Ishii N; Borst J
J Immunol; 2005 Aug; 175(3):1665-76. PubMed ID: 16034107
[TBL] [Abstract][Full Text] [Related]
11. Defects in the acquisition of CD8 T cell effector function after priming with tumor or soluble antigen can be overcome by the addition of an OX40 agonist.
Redmond WL; Gough MJ; Charbonneau B; Ratliff TL; Weinberg AD
J Immunol; 2007 Dec; 179(11):7244-53. PubMed ID: 18025166
[TBL] [Abstract][Full Text] [Related]
12. Dual anti-OX40/IL-2 therapy augments tumor immunotherapy via IL-2R-mediated regulation of OX40 expression.
Redmond WL; Triplett T; Floyd K; Weinberg AD
PLoS One; 2012; 7(4):e34467. PubMed ID: 22496812
[TBL] [Abstract][Full Text] [Related]
13. Exogenous OX40 stimulation during lymphocytic choriomeningitis virus infection impairs follicular Th cell differentiation and diverts CD4 T cells into the effector lineage by upregulating Blimp-1.
Boettler T; Choi YS; Salek-Ardakani S; Cheng Y; Moeckel F; Croft M; Crotty S; von Herrath M
J Immunol; 2013 Nov; 191(10):5026-35. PubMed ID: 24101548
[TBL] [Abstract][Full Text] [Related]
14. Synergistic OX40 and CD30 signals sustain CD8+ T cells during antigenic challenge.
Bekiaris V; Gaspal F; Kim MY; Withers DR; Sweet C; Anderson G; Lane PJ
Eur J Immunol; 2009 Aug; 39(8):2120-5. PubMed ID: 19609980
[TBL] [Abstract][Full Text] [Related]
15. Functional dichotomy between OX40 and 4-1BB in modulating effector CD8 T cell responses.
Lee SW; Park Y; Song A; Cheroutre H; Kwon BS; Croft M
J Immunol; 2006 Oct; 177(7):4464-72. PubMed ID: 16982882
[TBL] [Abstract][Full Text] [Related]
16. The TNFR family members OX40 and CD27 link viral virulence to protective T cell vaccines in mice.
Salek-Ardakani S; Flynn R; Arens R; Yagita H; Smith GL; Borst J; Schoenberger SP; Croft M
J Clin Invest; 2011 Jan; 121(1):296-307. PubMed ID: 21183789
[TBL] [Abstract][Full Text] [Related]
17. OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells.
Rogers PR; Song J; Gramaglia I; Killeen N; Croft M
Immunity; 2001 Sep; 15(3):445-55. PubMed ID: 11567634
[TBL] [Abstract][Full Text] [Related]
18. Combination OX40 agonism/CTLA-4 blockade with HER2 vaccination reverses T-cell anergy and promotes survival in tumor-bearing mice.
Linch SN; Kasiewicz MJ; McNamara MJ; Hilgart-Martiszus IF; Farhad M; Redmond WL
Proc Natl Acad Sci U S A; 2016 Jan; 113(3):E319-27. PubMed ID: 26729864
[TBL] [Abstract][Full Text] [Related]
19. The role of OX40-mediated co-stimulation in T-cell activation and survival.
Redmond WL; Ruby CE; Weinberg AD
Crit Rev Immunol; 2009; 29(3):187-201. PubMed ID: 19538134
[TBL] [Abstract][Full Text] [Related]
20. Costimulation of CD8 T cell responses by OX40.
Bansal-Pakala P; Halteman BS; Cheng MH; Croft M
J Immunol; 2004 Apr; 172(8):4821-5. PubMed ID: 15067059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
